Substituted pyrrolopyridines as ATR inhibitors
US11236089B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 26, 2020 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Apr 16, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure includes compounds of Formula (I) wherein A, W, m, R5, R6, R7, and R8, are defined herein. Also disclosed is a method for treating a neoplastic disease with these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.